Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families

Laura Obici, Giovanni Palladini, Sofia Giorgetti, Vittorio Bellotti, Gina Gregorini, Eloisa Arbustini, Laura Verga, Sabrina Marciano, Simona Donadei, Vittorio Perfetti, Laura Calabresi, Cesare Bergonzi, Francesco Scolari, Giampaolo Merlini

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background & Aims: Hereditary systemic amyloidoses are autosomal dominant, late-onset disorders caused by mutations in the genes for a group of plasma proteins including transthyretin, lysozyme, fibrinogen Aα chain, gelsolin, apolipoprotein A-I, and apolipoprotein A-II. We investigated both phenotypic and genotypic aspects of apolipoprotein A-I amyloidosis unexpectedly disclosed by liver biopsy in 13 unrelated individuals with asymptomatic, persistent elevation of alkaline phosphatase and γ-glutamyltransferase levels. Methods: Immunoelectron microscopy was used for in situ characterization of amyloid deposits on liver biopsy specimens. Mutation analysis was performed by sequencing of the apolipoprotein A-I gene in all patients. Wild-type/variant apolipoprotein A-I ratio in plasma high-density lipoproteins was assessed by a peptide mass fingerprinting approach after purification of total apolipoprotein A-I of 2 patients. Results: Family history was informative in 5 cases. Renal failure developed in 9 cases. Hypogonadism due to testicular involvement was observed. Amyloid fibrils specifically stained with anti-apolipoprotein A-I antibody. A novel (Leu75Pro) heterozygous mutation in the apolipoprotein A-I gene was present in affected individuals but not in controls. Variant apolipoprotein A-I was about 10% of the total protein in high-density lipoproteins. Conclusions. The high number of individuals with apparently sporadic disease might reflect widespread occurrence of this mutation in the population and a milder phenotype of this variant compared with other apolipoprotein A-I amyloidogenic mutants. These findings suggest that specific staining for amyloid should be performed on liver biopsy of individuals with asymptomatic chronic elevation of alkaline phosphatase and γ-glutamyltransferase levels.

Original languageEnglish
Pages (from-to)1416-1422
Number of pages7
JournalGastroenterology
Volume126
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

Familial Amyloidosis
Apolipoprotein A-I
Biopsy
Liver
Apolipoprotein A-II
Mutation
HDL Lipoproteins
Amyloid
Alkaline Phosphatase
Gelsolin
Genes
Prealbumin
Peptide Mapping
Hypogonadism
Immunoelectron Microscopy
Amyloid Plaques
Amyloidosis
Muramidase
Fibrinogen
Renal Insufficiency

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families. / Obici, Laura; Palladini, Giovanni; Giorgetti, Sofia; Bellotti, Vittorio; Gregorini, Gina; Arbustini, Eloisa; Verga, Laura; Marciano, Sabrina; Donadei, Simona; Perfetti, Vittorio; Calabresi, Laura; Bergonzi, Cesare; Scolari, Francesco; Merlini, Giampaolo.

In: Gastroenterology, Vol. 126, No. 5, 05.2004, p. 1416-1422.

Research output: Contribution to journalArticle

Obici, Laura ; Palladini, Giovanni ; Giorgetti, Sofia ; Bellotti, Vittorio ; Gregorini, Gina ; Arbustini, Eloisa ; Verga, Laura ; Marciano, Sabrina ; Donadei, Simona ; Perfetti, Vittorio ; Calabresi, Laura ; Bergonzi, Cesare ; Scolari, Francesco ; Merlini, Giampaolo. / Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families. In: Gastroenterology. 2004 ; Vol. 126, No. 5. pp. 1416-1422.
@article{cab6f54e60d44a0c8c16f3dd9865410f,
title = "Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families",
abstract = "Background & Aims: Hereditary systemic amyloidoses are autosomal dominant, late-onset disorders caused by mutations in the genes for a group of plasma proteins including transthyretin, lysozyme, fibrinogen Aα chain, gelsolin, apolipoprotein A-I, and apolipoprotein A-II. We investigated both phenotypic and genotypic aspects of apolipoprotein A-I amyloidosis unexpectedly disclosed by liver biopsy in 13 unrelated individuals with asymptomatic, persistent elevation of alkaline phosphatase and γ-glutamyltransferase levels. Methods: Immunoelectron microscopy was used for in situ characterization of amyloid deposits on liver biopsy specimens. Mutation analysis was performed by sequencing of the apolipoprotein A-I gene in all patients. Wild-type/variant apolipoprotein A-I ratio in plasma high-density lipoproteins was assessed by a peptide mass fingerprinting approach after purification of total apolipoprotein A-I of 2 patients. Results: Family history was informative in 5 cases. Renal failure developed in 9 cases. Hypogonadism due to testicular involvement was observed. Amyloid fibrils specifically stained with anti-apolipoprotein A-I antibody. A novel (Leu75Pro) heterozygous mutation in the apolipoprotein A-I gene was present in affected individuals but not in controls. Variant apolipoprotein A-I was about 10{\%} of the total protein in high-density lipoproteins. Conclusions. The high number of individuals with apparently sporadic disease might reflect widespread occurrence of this mutation in the population and a milder phenotype of this variant compared with other apolipoprotein A-I amyloidogenic mutants. These findings suggest that specific staining for amyloid should be performed on liver biopsy of individuals with asymptomatic chronic elevation of alkaline phosphatase and γ-glutamyltransferase levels.",
author = "Laura Obici and Giovanni Palladini and Sofia Giorgetti and Vittorio Bellotti and Gina Gregorini and Eloisa Arbustini and Laura Verga and Sabrina Marciano and Simona Donadei and Vittorio Perfetti and Laura Calabresi and Cesare Bergonzi and Francesco Scolari and Giampaolo Merlini",
year = "2004",
month = "5",
doi = "10.1053/j.gastro.2004.03.003",
language = "English",
volume = "126",
pages = "1416--1422",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families

AU - Obici, Laura

AU - Palladini, Giovanni

AU - Giorgetti, Sofia

AU - Bellotti, Vittorio

AU - Gregorini, Gina

AU - Arbustini, Eloisa

AU - Verga, Laura

AU - Marciano, Sabrina

AU - Donadei, Simona

AU - Perfetti, Vittorio

AU - Calabresi, Laura

AU - Bergonzi, Cesare

AU - Scolari, Francesco

AU - Merlini, Giampaolo

PY - 2004/5

Y1 - 2004/5

N2 - Background & Aims: Hereditary systemic amyloidoses are autosomal dominant, late-onset disorders caused by mutations in the genes for a group of plasma proteins including transthyretin, lysozyme, fibrinogen Aα chain, gelsolin, apolipoprotein A-I, and apolipoprotein A-II. We investigated both phenotypic and genotypic aspects of apolipoprotein A-I amyloidosis unexpectedly disclosed by liver biopsy in 13 unrelated individuals with asymptomatic, persistent elevation of alkaline phosphatase and γ-glutamyltransferase levels. Methods: Immunoelectron microscopy was used for in situ characterization of amyloid deposits on liver biopsy specimens. Mutation analysis was performed by sequencing of the apolipoprotein A-I gene in all patients. Wild-type/variant apolipoprotein A-I ratio in plasma high-density lipoproteins was assessed by a peptide mass fingerprinting approach after purification of total apolipoprotein A-I of 2 patients. Results: Family history was informative in 5 cases. Renal failure developed in 9 cases. Hypogonadism due to testicular involvement was observed. Amyloid fibrils specifically stained with anti-apolipoprotein A-I antibody. A novel (Leu75Pro) heterozygous mutation in the apolipoprotein A-I gene was present in affected individuals but not in controls. Variant apolipoprotein A-I was about 10% of the total protein in high-density lipoproteins. Conclusions. The high number of individuals with apparently sporadic disease might reflect widespread occurrence of this mutation in the population and a milder phenotype of this variant compared with other apolipoprotein A-I amyloidogenic mutants. These findings suggest that specific staining for amyloid should be performed on liver biopsy of individuals with asymptomatic chronic elevation of alkaline phosphatase and γ-glutamyltransferase levels.

AB - Background & Aims: Hereditary systemic amyloidoses are autosomal dominant, late-onset disorders caused by mutations in the genes for a group of plasma proteins including transthyretin, lysozyme, fibrinogen Aα chain, gelsolin, apolipoprotein A-I, and apolipoprotein A-II. We investigated both phenotypic and genotypic aspects of apolipoprotein A-I amyloidosis unexpectedly disclosed by liver biopsy in 13 unrelated individuals with asymptomatic, persistent elevation of alkaline phosphatase and γ-glutamyltransferase levels. Methods: Immunoelectron microscopy was used for in situ characterization of amyloid deposits on liver biopsy specimens. Mutation analysis was performed by sequencing of the apolipoprotein A-I gene in all patients. Wild-type/variant apolipoprotein A-I ratio in plasma high-density lipoproteins was assessed by a peptide mass fingerprinting approach after purification of total apolipoprotein A-I of 2 patients. Results: Family history was informative in 5 cases. Renal failure developed in 9 cases. Hypogonadism due to testicular involvement was observed. Amyloid fibrils specifically stained with anti-apolipoprotein A-I antibody. A novel (Leu75Pro) heterozygous mutation in the apolipoprotein A-I gene was present in affected individuals but not in controls. Variant apolipoprotein A-I was about 10% of the total protein in high-density lipoproteins. Conclusions. The high number of individuals with apparently sporadic disease might reflect widespread occurrence of this mutation in the population and a milder phenotype of this variant compared with other apolipoprotein A-I amyloidogenic mutants. These findings suggest that specific staining for amyloid should be performed on liver biopsy of individuals with asymptomatic chronic elevation of alkaline phosphatase and γ-glutamyltransferase levels.

UR - http://www.scopus.com/inward/record.url?scp=11144353836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144353836&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2004.03.003

DO - 10.1053/j.gastro.2004.03.003

M3 - Article

VL - 126

SP - 1416

EP - 1422

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -